Central Retinal Artery Occlusion - Our Future Path to the Introduction of Intravenous Thrombolysis.

Key Points

• To evaluate the therapeutic effect of intravenous procaine hydrochloride in central retinal artery occlusion.
• Administered 0.2% procaine hydrochloride intravenously
• Assessed potential therapeutic effects
• Analyzed the need for IVT administration protocols
• No therapeutic effect was demonstrated from 0.2% procaine hydrochloride administration
• Confirmed necessity for establishing a protocol for intravenous thrombolysis (IVT)